267 related articles for article (PubMed ID: 8856831)
61. Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors.
Petitet F; Jeantaud B; Reibaud M; Imperato A; Dubroeucq MC
Life Sci; 1998; 63(1):PL1-6. PubMed ID: 9667767
[TBL] [Abstract][Full Text] [Related]
62. Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats.
Fadda P; Robinson L; Fratta W; Pertwee RG; Riedel G
Neuropharmacology; 2004 Dec; 47(8):1170-9. PubMed ID: 15567426
[TBL] [Abstract][Full Text] [Related]
63. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
Wagner JA; Járai Z; Bátkai S; Kunos G
Eur J Pharmacol; 2001 Jul; 423(2-3):203-10. PubMed ID: 11448486
[TBL] [Abstract][Full Text] [Related]
64. Two distinctive antinociceptive systems in rats with pathological pain.
Mao J; Price DD; Lu J; Keniston L; Mayer DJ
Neurosci Lett; 2000 Feb; 280(1):13-6. PubMed ID: 10696800
[TBL] [Abstract][Full Text] [Related]
65. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats.
Wiley JL; Barrett RL; Lowe J; Balster RL; Martin BR
Neuropharmacology; 1995 Jun; 34(6):669-76. PubMed ID: 7566504
[TBL] [Abstract][Full Text] [Related]
66. Prostaglandin E2 attenuates SR141716A-precipitated withdrawal in tetrahydrocannabinol-dependent mice.
Anggadiredja K; Yamaguchi T; Tanaka H; Shoyama Y; Watanabe S; Yamamoto T
Brain Res; 2003 Mar; 966(1):47-53. PubMed ID: 12646307
[TBL] [Abstract][Full Text] [Related]
67. Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells.
Di Toro R; Campana G; Sciarretta V; Murari G; Spampinato S
Life Sci; 1998; 63(14):PL197-204. PubMed ID: 9771917
[TBL] [Abstract][Full Text] [Related]
68. Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells.
Rao GK; Zhang W; Kaminski NE
J Leukoc Biol; 2004 May; 75(5):884-92. PubMed ID: 14966196
[TBL] [Abstract][Full Text] [Related]
69. CB(1) receptor mediation of cannabinoid behavioral effects in male and female rats.
Tseng AH; Craft RM
Psychopharmacology (Berl); 2004 Feb; 172(1):25-30. PubMed ID: 14991224
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
Carta G; Nava F; Gessa GL
Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
[TBL] [Abstract][Full Text] [Related]
71. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
72. Effects of delta9-THC and WIN-55,212-2 on place preference in the water maze in rats.
Robinson L; Hinder L; Pertwee RG; Riedel G
Psychopharmacology (Berl); 2003 Feb; 166(1):40-50. PubMed ID: 12488948
[TBL] [Abstract][Full Text] [Related]
73. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol.
Tanda G; Loddo P; Di Chiara G
Eur J Pharmacol; 1999 Jul; 376(1-2):23-6. PubMed ID: 10440085
[TBL] [Abstract][Full Text] [Related]
74. SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task.
Wolff MC; Leander JD
Eur J Pharmacol; 2003 Sep; 477(3):213-7. PubMed ID: 14522359
[TBL] [Abstract][Full Text] [Related]
75. Delta(9)-tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons: involvement of CB(1) receptors.
Tomasini MC; Ferraro L; Bebe BW; Tanganelli S; Cassano T; Cuomo V; Antonelli T
J Neurosci Res; 2002 May; 68(4):449-53. PubMed ID: 11992471
[TBL] [Abstract][Full Text] [Related]
76. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.
Cox ML; Haller VL; Welch SP
Eur J Pharmacol; 2007 Sep; 570(1-3):50-6. PubMed ID: 17588560
[TBL] [Abstract][Full Text] [Related]
77. Disruptive effects of the prototypical cannabinoid Δ⁹-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats.
Sokolic L; Long LE; Hunt GE; Arnold JC; McGregor IS
Behav Pharmacol; 2011 Jun; 22(3):191-202. PubMed ID: 21512341
[TBL] [Abstract][Full Text] [Related]
78. Chronic Delta9-tetrahydrocannabinol during adolescence increases sensitivity to subsequent cannabinoid effects in delayed nonmatch-to-position in rats.
Wiley JL; Burston JJ
Pharmacol Biochem Behav; 2010 Feb; 94(4):516-23. PubMed ID: 19941884
[TBL] [Abstract][Full Text] [Related]
79. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
Lay L; Angus JA; Wright CE
Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
[TBL] [Abstract][Full Text] [Related]
80. Kamikihi-to, a Kampo medicine, ameliorates impairment of spatial memory in rats.
Egashira N; Manome N; Kurauchi K; Matsumoto Y; Iwasaki K; Mishima K; Shoyama Y; Fujiwara M
Phytother Res; 2007 Feb; 21(2):126-9. PubMed ID: 17117451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
